SPONSOR
Singapore Eye Research Institute
Total Trials
4
Recruiting
4
Phases
Phase 1
Conditions studied: Mild to Moderate Corneal Endothelial DecompensationBullous KeratopathyFuchs' Endothelial DystrophyPost-surgical Corneal Decompensation (Irreversible)Corneal DiseasesCorneal Scars and OpacitiesCorneal EdemaNeuropathic Corneal PainGlaucoma
Singapore Eye Research Institute is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Mild to Moderate Corneal Endothelial Decompensation, Bullous Keratopathy, Fuchs' Endothelial Dystrophy, Post-surgical Corneal Decompensation (Irreversible).
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Singapore Eye Research Institute
How many clinical trials has Singapore Eye Research Institute sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Singapore Eye Research Institute, of which 4 are actively recruiting participants. These trials cover conditions including Mild to Moderate Corneal Endothelial Decompensation, Bullous Keratopathy, Fuchs' Endothelial Dystrophy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Singapore Eye Research Institute research focus on?
Singapore Eye Research Institute clinical trials span Mild to Moderate Corneal Endothelial Decompensation, Bullous Keratopathy, Fuchs' Endothelial Dystrophy, Post-surgical Corneal Decompensation (Irreversible), Corneal Diseases, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Singapore Eye Research Institute clinical trial?
To participate in a Singapore Eye Research Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Singapore Eye Research Institute trials with current recruitment status updated daily.
Clinical Trials by Singapore Eye Research Institute
NCT04319848 Phase 1
Recruiting
Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty
Mild to Moderate Corneal Endothelial Decompensation
NCT06983652
Recruiting
Validation of the Use of Terahertz Scanning System on Corneal Scars and Corneal Edema
Corneal Diseases
NCT07174739
Recruiting
Efficacy of Quantum Molecular Resonance in Neuropathic Corneal Pain and Corneal Nerve Regeneration
Neuropathic Corneal Pain
NCT07243665
Recruiting
Glaucoma Screening Using Artificial Intelligence Assisted Clinical Model in Singapore's Diabetic Eye Screening Program
Glaucoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology